Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1076954

Rosuvastatin-induced rhabdomyolysis – the possible role of ticagrelor and the patient’s pharmacogenetic profile: a case report


Ladić, Iva; Vrkić Kirhmajer, Majda; Putarek, Krešimir; Banfić, Ljiljana; Božina, Nada
Rosuvastatin-induced rhabdomyolysis – the possible role of ticagrelor and the patient’s pharmacogenetic profile: a case report // Cardiol Croat. 2018 ; 13(1-2):36
Zagreb: Medical Publishing, d.o.o., 2018. str. 36-36 doi:10.15836/ccar2018.36 (poster, recenziran, prošireni sažetak, znanstveni)


CROSBI ID: 1076954 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Rosuvastatin-induced rhabdomyolysis – the possible role of ticagrelor and the patient’s pharmacogenetic profile: a case report

Autori
Ladić, Iva ; Vrkić Kirhmajer, Majda ; Putarek, Krešimir ; Banfić, Ljiljana ; Božina, Nada

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, prošireni sažetak, znanstveni

Izvornik
Cardiol Croat. 2018 ; 13(1-2):36 / - Zagreb : Medical Publishing, d.o.o., 2018, 36-36

Skup
CroIntervent

Mjesto i datum
Zagreb, Hrvatska, 8 - 10. 3. 2018

Vrsta sudjelovanja
Poster

Vrsta recenzije
Recenziran

Ključne riječi
rhabdomyolysis, rosuvastatin, ticagrelor

Sažetak
Dual antiplatelet therapy and statins are the cornerstone of acute coronary syndrome (ACS) treatment. Interaction between these drugs can be affected by differences in inter- individual pharmacokinetics/pharmacogenetics. Rhabdomyolysis is adverse reaction of statins. Previous reports suggested that concomitant use of ticagrelor may add an additional risk in developing statin induced rhabdomyolysis. We present a case of rosuvastatin and ticagrelor induced rhabdomyolysis

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Ladić, Iva; Vrkić Kirhmajer, Majda; Putarek, Krešimir; Banfić, Ljiljana; Božina, Nada
Rosuvastatin-induced rhabdomyolysis – the possible role of ticagrelor and the patient’s pharmacogenetic profile: a case report // Cardiol Croat. 2018 ; 13(1-2):36
Zagreb: Medical Publishing, d.o.o., 2018. str. 36-36 doi:10.15836/ccar2018.36 (poster, recenziran, prošireni sažetak, znanstveni)
Ladić, I., Vrkić Kirhmajer, M., Putarek, K., Banfić, L. & Božina, N. (2018) Rosuvastatin-induced rhabdomyolysis – the possible role of ticagrelor and the patient’s pharmacogenetic profile: a case report. U: Cardiol Croat. 2018 ; 13(1-2):36 doi:10.15836/ccar2018.36.
@article{article, author = {Ladi\'{c}, Iva and Vrki\'{c} Kirhmajer, Majda and Putarek, Kre\v{s}imir and Banfi\'{c}, Ljiljana and Bo\v{z}ina, Nada}, year = {2018}, pages = {36-36}, DOI = {10.15836/ccar2018.36}, keywords = {rhabdomyolysis, rosuvastatin, ticagrelor}, doi = {10.15836/ccar2018.36}, title = {Rosuvastatin-induced rhabdomyolysis – the possible role of ticagrelor and the patient’s pharmacogenetic profile: a case report}, keyword = {rhabdomyolysis, rosuvastatin, ticagrelor}, publisher = {Medical Publishing, d.o.o.}, publisherplace = {Zagreb, Hrvatska} }
@article{article, author = {Ladi\'{c}, Iva and Vrki\'{c} Kirhmajer, Majda and Putarek, Kre\v{s}imir and Banfi\'{c}, Ljiljana and Bo\v{z}ina, Nada}, year = {2018}, pages = {36-36}, DOI = {10.15836/ccar2018.36}, keywords = {rhabdomyolysis, rosuvastatin, ticagrelor}, doi = {10.15836/ccar2018.36}, title = {Rosuvastatin-induced rhabdomyolysis – the possible role of ticagrelor and the patient’s pharmacogenetic profile: a case report}, keyword = {rhabdomyolysis, rosuvastatin, ticagrelor}, publisher = {Medical Publishing, d.o.o.}, publisherplace = {Zagreb, Hrvatska} }

Časopis indeksira:


  • Scopus


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font